Nicole Engel-Nitz

1.1k total citations · 1 hit paper
40 papers, 767 citations indexed

About

Nicole Engel-Nitz is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics. According to data from OpenAlex, Nicole Engel-Nitz has authored 40 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 11 papers in Economics and Econometrics. Recurrent topics in Nicole Engel-Nitz's work include Economic and Financial Impacts of Cancer (8 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Prostate Cancer Treatment and Research (5 papers). Nicole Engel-Nitz is often cited by papers focused on Economic and Financial Impacts of Cancer (8 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Prostate Cancer Treatment and Research (5 papers). Nicole Engel-Nitz collaborates with scholars based in United States, United Kingdom and India. Nicole Engel-Nitz's co-authors include John I. Allen, Eva Szigethy, Caren Heller, Rachel Lawton, Sean M. Murphy, Orna Ehrlich, Miguel Regueiro, David T. Rubin, Sandra C. Kim and K T Park and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Urology.

In The Last Decade

Nicole Engel-Nitz

38 papers receiving 753 citations

Hit Papers

The Cost of Inflammatory Bowel Disease: An Initiative Fro... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole Engel-Nitz United States 13 264 208 147 119 110 40 767
Érick Moyneur United States 16 293 1.1× 240 1.2× 242 1.6× 78 0.7× 87 0.8× 43 1.2k
Palle Bager Denmark 19 541 2.0× 414 2.0× 140 1.0× 311 2.6× 57 0.5× 46 1.2k
Mohammad Movahedi Canada 15 88 0.3× 79 0.4× 134 0.9× 62 0.5× 32 0.3× 76 838
Ioannis Kyvernitakis Germany 19 170 0.6× 161 0.8× 467 3.2× 115 1.0× 34 0.3× 70 1.1k
Louise Stanton United Kingdom 15 87 0.3× 182 0.9× 443 3.0× 88 0.7× 30 0.3× 36 856
Aaron B. Cohen United States 14 213 0.8× 168 0.8× 154 1.0× 188 1.6× 65 0.6× 52 645
Sierra Matula United States 8 517 2.0× 405 1.9× 207 1.4× 211 1.8× 71 0.6× 13 856
Luc J. J. Derijks Netherlands 22 632 2.4× 366 1.8× 65 0.4× 205 1.7× 38 0.3× 65 1.5k
Jakub Závada Czechia 19 59 0.2× 173 0.8× 73 0.5× 105 0.9× 105 1.0× 59 1.2k
Miguel Ángel Calleja‐Hernández Spain 19 61 0.2× 69 0.3× 256 1.7× 125 1.1× 51 0.5× 75 1.0k

Countries citing papers authored by Nicole Engel-Nitz

Since Specialization
Citations

This map shows the geographic impact of Nicole Engel-Nitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Engel-Nitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Engel-Nitz more than expected).

Fields of papers citing papers by Nicole Engel-Nitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Engel-Nitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Engel-Nitz. The network helps show where Nicole Engel-Nitz may publish in the future.

Co-authorship network of co-authors of Nicole Engel-Nitz

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Engel-Nitz. A scholar is included among the top collaborators of Nicole Engel-Nitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Engel-Nitz. Nicole Engel-Nitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sholzberg, Michelle, Angela C. Weyand, Benjamin Kim, et al.. (2024). Diagnosis and Disease Burden of Von Willebrand Disease in a Large US Population Based-Dataset. Blood. 144(Supplement 1). 3980–3980.
3.
Engel-Nitz, Nicole, et al.. (2023). Iron Deficiency Anemia: The Impact of Intravenous Iron Replacement Treatment on Health Care Costs. Blood. 142(Supplement 1). 3697–3697. 1 indexed citations
4.
Engel-Nitz, Nicole, et al.. (2023). Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient Preference and Adherence. Volume 17. 1049–1062. 4 indexed citations
6.
Engel-Nitz, Nicole, et al.. (2023). Patient and provider factors associated with colorectal cancer screening among average risk health plan enrollees in the US, 2015–2018. BMC Health Services Research. 23(1). 3 indexed citations
7.
Engel-Nitz, Nicole, et al.. (2022). Colorectal screening among average risk individuals in the United States, 2015–2018. Preventive Medicine Reports. 31. 102082–102082. 4 indexed citations
8.
Szigethy, Eva, Sean M. Murphy, Orna Ehrlich, et al.. (2021). Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease. Crohn s & Colitis 360. 3(2). otab021–otab021. 1 indexed citations
11.
Szigethy, Eva, Sean M. Murphy, Orna Ehrlich, et al.. (2020). Mental Health Costs of Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. 27(1). 40–48. 36 indexed citations
12.
Martı́nez, Carolina, Nicole Engel-Nitz, Stacey DaCosta Byfield, et al.. (2019). Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer. The Oncologist. 24(9). 1209–1218. 24 indexed citations
13.
Engel-Nitz, Nicole, et al.. (2015). Costs and mortality of recurrent versus de novo hormone receptor-positive/HER2 - metastatic breast cancer. Journal of Comparative Effectiveness Research. 4(4). 303–314. 6 indexed citations
14.
Engel-Nitz, Nicole, Sarika Ogale, & Mahesh Kulakodlu. (2015). Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs. Rheumatology and Therapy. 2(2). 127–139. 10 indexed citations
15.
Engel-Nitz, Nicole, et al.. (2014). Diagnostic testing managed by hematopathology specialty and other laboratories: costs and patient diagnostic outcomes. BMC Clinical Pathology. 14(1). 17–17. 4 indexed citations
16.
Garris, Cindy, Priti Jhingran, Damon Bass, et al.. (2013). Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan. Journal of Medical Economics. 16(5). 667–677. 85 indexed citations
17.
Whyte, Joanna L., et al.. (2013). An Evaluation of Algorithms for Identifying Metastatic Breast, Lung, or Colorectal Cancer in Administrative Claims Data. Medical Care. 53(7). e49–e57. 81 indexed citations
18.
Mowat, Fionna, Michael A. Kelsh, Jason C. Legg, et al.. (2011). PCN129 USE OF ELECTRONIC MEDICAL RECORDS (EMR) FOR ONCOLOGY OUTCOMES RESEARCH: ASSESSING THE COMPARABILITY OF EMR INFORMATION TO PATIENT REGISTRY AND HEALTH CLAIMS DATA. Value in Health. 14(3). A178–A178. 5 indexed citations
19.
Engel-Nitz, Nicole, Theodore Darkow, & H. Lau. (2010). Antihypertensive medication changes and blood pressure goal achievement in a managed care population. Journal of Human Hypertension. 24(10). 659–668. 9 indexed citations
20.
Engel-Nitz, Nicole, Sherry Martin, Peter P. Sun, Don P. Buesching, & Vivian Fonseca. (2008). Cardiovascular events and insulin therapy: A retrospective cohort analysis. Diabetes Research and Clinical Practice. 81(1). 97–104. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026